Two fully automated drug-monitoring systems, the Syva Autolab 6000 and the Beckman Auto ICS, were compared in terms of accuracy, precision, speed of operation, and cost effectiveness in the determination of gentamicin levels in serum. Within-run and between-run precision for both systems were acceptable (coefficient of variation, 2.0 to 6.9%), and patient sample comparisons resulted in an intermethod correlation coefficient of 0.96. When reference samples (prepared to contain 1.2 to 10 ,ug of gentamicin per ml) were assayed, the Syva Autolab 6000 obtained concentrations within 8% of expected values, whereas the Beckman Auto ICS reported values up to 17% higher than target values. In a time and cost comparison, reagent costs for the Beckman system were ca. 50% less than for the Syva Autolab 6000; the Syva system, however, determined patient results two to three times faster than the Beckman Auto ICS.
Gentamicin is a potent aminoglycoside antibiotic often used in the treatment of severe gram-negative bacillary infections. For safe and efficacious therapy to be achieved, gentamicin levels in serum must be maintained within a narrow concentration range so as to allow the infecting organism to be killed while minimizing nephrotoxic or ototoxic side effects to the patient (1, 5, 9) . Due to varying aminoglycoside elimination rates among patients, prediction of adequate gentamicin levels in serum based solely on calculated dosages is often misleading, reinforcing the need for laboratory monitoring of gentamicin levels in serum (2, 10, 13) .
Many methods are currently available for measuring aminoglycoside levels, including bioassay, radioimmunoassay (RIA), high-pressure liquid chromatography, enzyme immunoassay, and fluorescent immunoassay (3, 4, 8, 11, 12) . For clinical laboratories with large drug-monitoring work loads, fully automated systems have been developed which significantly reduce technologist time and generate results faster. The Autolab 6000, an automated system recently introduced by Syva Co., uses a homogeneous enzymelinked immunoassay technique (EMIT) which has been shown to be accurate, specific, and easy to perform (6) (7) (8) 11) . Beckman Instruments, Inc., has upgraded its ICS Analyzer II to an Auto ICS, an automated system which uses a rate nephelometric inhibition immunoassay to perform therapeutic drug determinations. Tables 3 and 4 . Set-up or hands-on time included reagent preparation, priming of the systems, dispensing of sera into sample cups, and logging sample identification information into the data processors (Table 3) . 16 .8% for their Syva system and Beckman Auto ICS, respectively, when evaluating the reproducibility of four gentamicin assays. These investigators experienced precision problems similar to ours with the Beckman Auto ICS and noted an improvement in precision after the manufacturer modified the instrument.
For within-run precision, Witebsky and co-workers (12) obtained a CV of 8.6% during the performance of tobramycin studies on the Beckman Auto ICS before adjustments were made to the system and a CV of 3.8% with tobramycin level determinations after modification of the Beckman Auto ICS. Similarly, we found a notable difference in within-run CVs between the Beckman Auto ICS initially (CV, 6.3 to 6.6%) and after technical adjustments had been made (CV, 2.0 to 2.9%). Within-run precision for the Syva Autolab 6000 was excellent as indicated by CVs of 2.5 to 3.2% and was in agreement with the findings of O'Leary et al. (6) , who obtained CVs of 1.7 to 3.1% with a manual EMIT procedure to measure gentamicin concentrations.
In terms of accuracy, Delaney and co-workers (4) found 86 to 92% recovery when assaying spiked gentamicin concentrations ranging from 2.2 to 32.7 ,utg/ml with a semiautomated Syva system. In our current study, the Syva Auto- Our time analysis indicates that technologist hands-on time for both systems is comparable. A notable difference between the two systems is found in the time needed to analyze a sample and report a final result, with the Beckman system requiring two to three times longer than the Syva system. However, with present price structure, reagent costs for the Beckman Auto ICS are ca. 50% less than for the Syva Autolab 6000. If the expenses for both reagents and time required to obtain final results are considered together, operation of the slower Beckman Auto ICS is ca. 20% less costly than the Syva Autolab 6000.
